EC chi hơn 70 triệu USD mua thuốc remdesivir điều trị COVID-19

Nhằm đáp ứng nhu cầu cấp bách hiện nay cho các bệnh nhân mắc dịch viêm đường hô hấp cấp COVID-19 ở châu Âu, ngày 29/7, Ủy ban châu Âu (EC) thông báo đã đồng ý mua thuốc kháng virus remdesivir vốn khan hiếm của công ty dược phẩm Mỹ Gilead Sciences.

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

Bình luận

Xin vui lòng gõ tiếng Việt có dấu

Tin cùng chuyên mục

Nga công bố 3 lô vaccine ung thư mRNA đầu tiên

Nga công bố 3 lô vaccine ung thư mRNA đầu tiên

Thế giới
(Baothanhhoa.vn) - Nga vừa giới thiệu 3 lô vaccine ung thư thử nghiệm đầu tiên, được phát triển tại Viện Gamaleya ở Moscow, nơi từng tạo ra vaccine COVID-19 Sputnik V. Đây là loại vaccine điều trị ung thư dựa trên công nghệ mRNA, kết hợp trí tuệ nhân tạo (AI) để tùy...
Time vinh danh “Các kiến trúc sư AI” là Nhân vật của Năm 2025

Time vinh danh “Các kiến trúc sư AI” là Nhân vật của Năm 2025

Thế giới
(Baothanhhoa.vn) - Tạp chí Time đã công bố lựa chọn “Architects of AI” (kiến trúc sư AI) là Nhân vật của năm 2025, nhằm ghi nhận tầm ảnh hưởng ngày càng sâu rộng của AI đối với truyền thông, chính trị, kinh tế và nhiều lĩnh vực khác của đời sống. Đây là lần đầu tiên...
Chứng nhận tín nhiệm mạng
Việt Long Phần mềm tòa soạn
hội tụ thông minh